RE: Webcast AftermathI think a few folks are impatient with the standstill timeframe, and perhaps rightly so with the fact we are way past the original date indicated by the company that the standstill would be signed. But I believe the company is finding out that the pharmas require a fair bit of info before they jump into any kind of a deal. In the process, the company keeps hiring top-notch research staff and scientific advisory folks that are doing research to increase the value of the product. I think management believes the product gets better each day and that is reflected in the 67% increase in the standstill price. The timeframe for buyout has been expanded, but if you are willing to wait, you will have the little carrot of RVX Therapeutics shares as well as a hopefully large cash payout as your reward.